BRG CENTRUM MEDYCZNE
- Address
- ul. Mokra 7, 05-830 Kajetany, Poland
BRG CENTRUM MEDYCZNE - Multiple Sclerosis Research Center
BRG CENTRUM MEDYCZNE is a clinical research facility participating in advanced neurological research, with specialized expertise in multiple sclerosis clinical trials. The center focuses on evaluating novel therapeutic interventions for patients with relapsing-remitting multiple sclerosis, contributing to the development of innovative treatment options that may improve disease management and patient outcomes.
- Phase 2 clinical trials in relapsing-remitting multiple sclerosis (RRMS)
- MRI-based disease activity assessment and monitoring
- Pharmacodynamic modeling and dose-response optimization studies
The research center demonstrates particular proficiency in conducting double-blind, placebo-controlled multicenter trials, emphasizing rigorous evaluation of both efficacy and safety profiles of investigational medications. Their involvement in pharmacodynamic modeling studies reflects a commitment to understanding optimal dosing strategies and treatment responses in neuroinflammatory conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Immunic AG1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in BRG CENTRUM MEDYCZNE
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of Vidofludimus Calcium on MRI-Assessed Disease Activity in Relapsing-Remitting Multiple Sclerosis | Immunic AG | Phase II | Recruiting | Jan 2019 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Vidofludimus Calcium | 1 | Unknown | 2019-01-23 | 2019-01-23 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.